Sexual Health Outcomes Improvement in Sickle Cell Disease: A Matter of Health Policy?

Journal of Sexual Medicine

Volumn 9, Issue 1, 2012, Pages 104-113

  Burnett, Arthur L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Erectile Dysfunction; Erection; Ischemic Priapism; Penis; Priapism; Stuttering Priapism

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; DIETHYLSTILBESTROL; EPHEDRINE; ETILEFRINE;

ARTERIOGRAPHY; ARTIFICIAL EMBOLISM; CULTURAL FACTOR; DRUG EFFICACY; ETHNICITY; FUNDING; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; MEDICAL RESEARCH; MEDLINE; MENTAL HEALTH; OUTCOME ASSESSMENT; PRIAPISM; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUAL HEALTH; SICKLE CELL ANEMIA; SOCIOECONOMICS; TREATMENT PLANNING;

EID: 84855343317     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02411.x     Document Type: Article

References (47)

1. Meremikwu MM. Sickle cell disease. Clin Evid 2009;2402:1-20.
2. Bender MA, Hobbs W. Sickle cell disease. In: Pagon RA, Bird TC, Dolan CR, Stephens K, eds. Gene reviews. Seattle, WA: University of Washington; 2009.
3. Burnett AL, Allen RP, Tempany CM, Dover GJ, Brendler CB. Evaluation of erectile function in men with sickle cell disease. Urology 1995;45:657-63.
4. Singhal A, Gabay L, Serjeant GR. Testosterone deficiency and extreme retardation of puberty in homozygous sickle-cell disease. West Indian Med J 1995;44:20-3.
5. Hinman F. Priapism: Report of cases and a clinical study of the literature with reference to its pathogenesis and surgical treatment. Ann Surg 1914;60:689-716.
6. Tiefer L. The emerging global discourse of sexual rights. J Sex Marital Ther 2002;28:439-44.
7. Wagner G, Bondil P, Dabees K, Dean J, Fourcroy J, Gingell C, Kingsberg S, Kothari P, Rubio-Aurioles E, Ugarte F, Navarrete RV. Ethical aspects of sexual medicine. J Sex Med 2005;2:163-8.
8. Nash KB. Overview of humanistic progress in sickle cell anemia during the past 10 years. Am J Pediatr Hematol Oncol 1983;5:352-9.
9. Manley AF. Legislation and funding for sickle cell services, 1972-1982. Am J Pediatr Hematol Oncol 1984;6:67-71.
10. Smith LA, Oyeku SO, Homer C, Zuckerman B. Sickle cell disease: A question of equity and quality. Pediatrics 2006;117:1763-70.
11. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38:S512-21.
12. Olney RS. Preventing morbidity and mortality from sickle cell disease: A public health perspective. Am J Prev Med 1999;16:116-21.
13. Makani J, Williams TN, Marsh K. Sickle cell disease in Africa: Burden and research priorities. Ann Trop Med Parasitol 2007;101:3-14.
14. Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980;140:1434-7.
15. Fowler JE Jr, Koshy M, Strub M, Chinn SK. Priapism associated with the sickle cell hemoglobinopathies: Prevalence, natural history and sequelae. J Urol 1991;145:65-8.
16. Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 1999;21:518-22.
17. Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D, Akenova A, Akinyanju O, Cinkotai K, O'Reilly PH. Priapism in sickle-cell disease; incidence, risk factors and complications-An international multicentre study. BJU Int 2002;90:898-902.
18. Burnett AL, Bivalacqua TJ. Priapism: Current principles and practice. Urol Clin North Am 2007;34:631-42.
19. Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med 2010;38:S550-6.
20. Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health for children and adults with sickle cell disease. Am J Hematol 2009;84:323-7.
21. Shankar SM, Arbogast PG, Mitchell E, Cooper WO, Wang WC, Griffin MR. Medical care utilization in sickle cell disease: A population-based study. Am J Hematol 2005;80:262-70.
22. Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA. Acute care utilization and rehospitalizations for sickle cell disease. JAMA 2010;303:1288-94.
23. Haywood C Jr, Beach MC, Lanzkron S, Strouse JJ, Wilson R, Park H, Witkop C, Bass EB, Segal JB. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc 2009;101:1022-33.
24. Boulet SL, Yanni EA, Creary MS, Olney RS. Health status and healthcare use in a national sample of children with sickle cell disease. Am J Prev Med 2010;38:S528-35.
25. Addis G, Spector R, Shaw E, Musumadi L, Dhanda C. The physical, social and psychological impact of priapism on adult males with sickle cell disorder. Chronic Illn 2007;3:145-54.
26. Datta NS. Megalophallus in sickle cell disease. J Urol 1977;117:672-3.
27. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID, Members of the Erectile Dysfunction Guideline Update Panel, American Urological Association. American Urological Association guideline on the management of priapism. J Urol 2003;170:1318-24.
28. Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, Mulhall J, Perovic S, Ralph D, Stackl W. Priapism. J Sex Med 2004;1:116-20.
29. Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, Hakim LS, Hellstrom W, Honig S, Levine LA, Lue T, Munarriz R, Montague DK, Mulcahy JJ, Nehra A, Rogers ZR, Rosen R, Seftel AD, Shabsigh R, Steers W. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res 2001;13(5 suppl):S39-43.
30. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: Pathogenesis, epidemiology, and management. J Sex Med 2010;7:476-500.
31. Hinman F Jr. Priapism; reasons for failure of therapy. J Urol 1960;83:420-8.
32. Burnett AL. Nitric oxide in the penis-Science and therapeutic implications from erectile dysfunction to priapism. J Sex Med 2006;3:578-82.
33. Chinegwundoh F, Anie KA. Treatments for priapism in boys and men with sickle cell disease. Cochrane Database Syst Rev 2009;1-15:CD004198.
34. Serjeant GR, de Ceulaer K, Maude GH. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 1985;2:1274-6.
35. Olujohungbe AB, Adeyoju A, Yardumian A, Akinyanju O, Morris J, Westerdale N, Akenova Y, Kehinde MO, Anie K, Howard J, Brooks A, Davis VA, Khoriaty AI. A prospective diary study of stuttering priapism in adolescents in young men with sickle cell anemia: Report of an international randomized control trial-the priapism in sickle cell study. J Androl 2011;32:375-82.
36. U.S. National Institutes of Health. Clinical Trials.gov. Sildenafil for treatment of priapism in men with sickle cell anemia. 2009. Available at: (accessed October 21, 2010).
37. Newacheck PW, McManus M, Fox HB, Hung YY, Halfon N. Access to health care for children with special care needs. Pediatrics 2000;105:760-6.
38. Rogers ZR. Priapism in sickle cell disease. Hematol Oncol Clin North Am 2005;19:917-28.
39. Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med 2008;5:1244-50.
40. Telfair J, Myers J, Drezner S. Does race influence the provision of care to persons with sickle cell disease? Perceptions of multidisciplinary providers. J Health Care Poor Underserved 1998;9:184-95.
41. Zempsky WT. Treatment of sickle cell pain: Fostering trust and justice. JAMA 2009;302:2479-80.
42. Butler DJ, Beltran LR. Functions of an adult sickle cell group: Education, task orientation, and support. Health Soc Work 1993;18:49-56.
43. Kinney TR, Ware RE. The adolescent with sickle cell anemia. Hematol Oncol Clin North Am 1996;10:1255-64.
44. Williams DR, Mohammed SA, Leavell J, Collins C. Race, socioeconomic status, and health: Complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci 2010;1186:69-101.
45. Anderson LM, Scrimshaw SC, Fullilove MT, Fielding JE, Normand J. Culturally competent healthcare systems: A systematic review. Am J Prev Med 2003;24:68-79.
46. Taylor SL, Lurie N. The role of culturally competent communication in reducing ethnic and racial healthcare disparities. Am J Manag Care 2004;10(Spec No):SP1-4.
47. Hassell K, Pace B, Wang W, Kulkarni R, Luban N, Johnson CS, Eckman J, Lane P, Woods WG. Sickle cell disease summit: From clinical and research disparity to action. Am J Hematol 2009;84:39-45.